Thursday 19 November 2026 Sign in / SubscribeFree daily emailMarket analysisEnterprise solutionsVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Manufacturing & supply

Victory Medical Center Pharmacy recalls biotin injection in three states, FDA says

The Class II action covers a 30 ml biotin product sold in Colorado, Florida and Texas; the FDA entry gives no figures on volume or commercial exposure.

11 Nov 2026 · FDA enforcement report · Regulator

A 30 ml biotin injection made by Victory Medical Center Pharmacy is the subject of a recall that the US Food and Drug Administration added to its enforcement report on 11 November 2026. The entry, numbered D-0118-2027, describes the product as biotin at 10 mg/ml in a multiple-dose presentation.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on CompePharma and VigiEye
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official record: FDA enforcement report ↗

Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.

More Manufacturing & supplyAll →